spacer
home > epc > summer 2002 > making the right choice in pharmaceutical outsourcing
PUBLICATIONS
European Pharmaceutical Contractor

Making the Right Choice in Pharmaceutical Outsourcing

Outsourcing of analysis within the pharmaceutical industry has steadily increased in recent years and this trend seems set to continue with estimated growth being as high as 9 per cent per annum.

Key reasons for outsourcing analysis include:

Little or no facilities in-house

Utilisation of internal competence on higher value return science, such
as better value for money from internal staff

In-house capacity problems due to increased testing in line with regulations

The problem of choosing the right outsourcing partner has been exacerbated by the growth in the number of contract service organisations (CSOs) on the market. Often these organisations appear to offer similar services and returns for the customer - thus making the partnering decision difficult.

This article will explore four key areas worthy of consideration when selecting your outsourcing laboratory.

Balancing Cost and Confidence

When faced with the prospect of outsourcing you must be convinced of the viability and robustness of your decision to hand over control of a project to a third party. As the project manager, you must be confident about getting value for money, quality and delivery from your outsourcing partner.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Brian Arnot, Business Development Executive at Tepnel Scientific Services

Brian Arnot is an experienced Analytical Chemist who has worked in the contract analytical services sector since 1984.

More recently, he has joined the business development team of Tepnel Scientific Services (formerly the Medicines Testing Laboratory), where he is responsible for the development of core business activities in both the UK and Europe.

spacer
Brian Arnot
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region. Government incentive schemes to increase domestic production, coupled with a brand friendly environment and rising healthcare needs is fuelling surging demand – with many new companies and plants launching in the last two years alone.
More info >>

White Papers

Backward Thinking: The Reverse Engineering of A Pressurized Metered Dose Inhaler

Development of a generic equivalent to a current marketed pressurized metered dose inhaler (pMDI) product brings immense challenges. Thorough analysis is critical to gain a comprehensive understanding of the physical attributes and pharmaceutical performance of the reference marketed product. Many factors need to be assessed, understood and combined in order to successfully develop a generic pMDI which will meet the regulatory and quality requirements as an equivalent product in the anticipated target market. Significant information about the reference marketed product can be obtained from a thorough review of published literature, specifically the Summary of Product Characteristics (SPC) and Patient Information Leaflet (PIL). Additionally, baselining the reference marketed product for pharmaceutical performance offers a working target specification for in-vitro correlation. It will ensure the smoothest possible path to commercialization and maximize return on investment. In addition, baselining of the reference marketed product is done to understand batch-to-batch variability and product performance over the stated shelf life to establish targets for critical quality attributes (CQAs), which can be applied to the generic equivalent pMDI.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement